Research Article

[Retracted] Higher Chronic Endometritis Incidences within Infertile Polycystic Ovary Syndrome Clinical Cases

Table 1

Clinical characteristics of patients (PCOS and non-PCOS cohorts).

PCOS cohort (n = 508)Non-PCOS cohort (n = 2828) value

Age, years31.03 ± 3.2031.98 ± 3.57<0.001
Infertility duration, years3.86 ± 2.323.65 ± 2.350.056
BMI (kg/m2)25.42 ± 3.6523.40 ± 3.42<0.001
Infertility
 Primary infertility %280 (55.12%)1410 (49.86%)0.029
 Secondary infertility %228 (44.88%)1418 (50.14%)
bFSH (UI/L)5.94 ± 1.416.84 ± 1.89<0.001
bLH (UI/L)8.91 ± 4.855.05 ± 2.01<0.001
bE2 (pg/ml)35.45 ± 12.0134.43 ± 13.860.128
bP (ng/ml)0.50 ± 0.300.52 ± 0.250.055
bT (ng/ml)0.40 ± 0.190.25 ± 0.12<0.001
PRL (ng/ml)16.30 ± 6.5517.35 ± 6.130.001
AMH (ng/ml)10.08 ± 6.364.14 ± 2.67<0.001
CA125 (U/ml)16.98 ± 7.8823.87 ± 9.59<0.001
CHOL (mmol/L)4.98 ± 0.944.74 ± 0.83<0.001
LDL-C (mmol/L)2.98 ± 0.812.81 ± 0.670.241
TG (mmol/L)1.42 ± 0.951.05 ± 0.84<0.001

bFSH, basal follicle-stimulating hormone; bLH, basal luteinizing hormone; bE2, basal estradiol; bP, basal progesterone; bT, basal total testosterone; PRL, prolactin. The limit of significance is a value <0.05, which was evaluated on the basis of the chi-square test.